OMERS Administration Corp’s Theravance Biopharma TBPH Stock Holding History

OMERS Administration Corp’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$327K	–	329
2018 Q3	$327K	Buy	+10,000	New	+$273K	﹤0.01%	332
2017 Q3	–	Sell	-9,500	Closed	-$378K	–	508
2017 Q2	$378K	Hold	9,500	–	–	﹤0.01%	403
2017 Q1	$350K	Buy	9,500 +2,300	+32%	+$73.5K	﹤0.01%	289
2016 Q4	$230K	Sell	7,200 -13,900	-66%	-$431K	﹤0.01%	292
2016 Q3	$765K	Hold	21,100	–	–	0.01%	397
2016 Q2	$479K	Buy	21,100 +7,272	+53%	+$157K	0.01%	462
2016 Q1	$260K	Buy	13,828 +2,419	+21%	+$39.6K	0.01%	497
2015 Q4	$187K	Buy	+11,409	New	+$181K	﹤0.01%	463

Other funds holding TBPH

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OMERS Administration Corp's TBPH Position: Q4 2018 in Review

OMERS Administration Corp sold out of Theravance Biopharma (TBPH) in Q4 2018, closing a stake of 10,000 shares — an estimated $327K sold.

OMERS Administration Corp first reported a position in TBPH in Q4 2015 and held it in 8 quarters. The position peaked at $765K in Q3 2016. 96 funds tracked by Wall St. Rank hold TBPH as of Q4 2018.

OMERS Administration Corp reported no remaining Theravance Biopharma position as of Q4 2018 after selling out during the quarter.
OMERS Administration Corp sold 10,000 Theravance Biopharma shares in Q4 2018, an estimated $327K.
OMERS Administration Corp first reported a position in Theravance Biopharma in Q4 2015 and held it in 8 quarters.
OMERS Administration Corp's Theravance Biopharma position peaked at $765K in Q3 2016.
96 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2018.

Based on OMERS Administration Corp's 13F filing for Q4 2018, filed 14 Feb 2019.